FedCentric Technologies, LLC Begins Collaboration With Frederick National Laboratory for Cancer Research

Aug 12, 2015, 11:28 ET from FedCentric Technologies, LLC

FAIRFAX, Va., Aug. 12, 2015 /PRNewswire/ -- FedCentric Technologies and the Frederick National Laboratory for Cancer Research (FNLCR) have entered into a collaborative agreement to develop a High-Performance Data Analytics (HPDA) platform to provide bioinformaticians with new insights into the genetic roots of cancer. A rapidly emerging technology, HPDA combines high-performance computing with advanced data analytics.

FedCentric has assembled a team of mathematicians and computer scientists to work closely with Jack Collins, Ph.D., and his research team at FNLCR to extract knowledge and insights from large, complex genomic databases in an ongoing effort to improve cancer diagnostics and treatments.  According to FNLCR, the goal of these collaborative agreements is to "accelerate treatment for cancer by bridging the gap between late discovery and early development of diagnostics and therapeutics, developing cross-cutting technology platforms, and developing data standards."

"This is a great example of what's possible when academia, industry, and government collaborate.  We're very excited to be working with Dr. Collins' team, and we look forward to seeing fruitful progress in this important pilot," said Gerry Kolosvary, CEO of FedCentric Technologies.

FedCentric has already developed and implemented HPDA solutions as the prime contractor with the United States Postal Service to significantly improve its computer-based logistics. The Office of Science and Technology Policy at The White House recognized FedCentric for its groundbreaking development of HPDA solutions for the United States Postal Service.

The Frederick National Laboratory for Cancer Research is a Federally Funded Research and Development Center sponsored by the National Cancer Institute. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E.  The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

FedCentric Technologies, LLC is responsible for the content of this announcement.

Contact:
Michael Atkins, PhD
Bioscience Advisor
8315 Lee Hwy, Suite 500
Fairfax, VA 22013
(301) 263-0030 ext. 528
michael.atkins@fedcentric.com

Logo - http://photos.prnewswire.com/prnh/20131003/PH91185LOGO

SOURCE FedCentric Technologies, LLC